Hot Topics

BREAKING: The FAMPH has published the Compendium on Biobank legislation

On February 5th 2018, the Royal Decree on the Belgian Biobank Legislation, regarding the procurement and use of human substances destined for human medical applications or for scientific research purposes, was published. If you make use of human cell line and human samples for your research, a notification to FAMPH of your organisation as an official ‘Biobank’ is required.

We are pleased to inform you that on 30 July 2018, the FAMPH has published on its website a Compendium to guide you through this new Biobank legislation and to answer your questions regarding the scope of this Law, the implementation and notification procedures, consent of the donor, ethics committee, manager of the biobank, … and many more. This Compendium was built by the FAMPH after consultation with stakeholders, from various sectors, impacted by the legal provisions on biobanks.

This Compendium as well as the Royal Decree can be found on the FAMPH website

We hope this Compendium will answer your questions and support you with the implementation of the Belgian Biobank Legislation within your organisation.

BeCRO will be present at the BCF Career Event on Nov 22

BeCRO live

BeCRO will be present at the “BCF Career Event Belgium” on November 22th in Gent.

Read more

BeCRO has partaken to the Knowledge for Growth conference on May 17, 2018

BeCRO live

10 of our members have shared a BeCRO booth on this 14th edition of the Knowledge for Growth conference in Ghent on May 17, 2018. It was a great success, with many visitors and top level conference talks.

Read more

GDPR, all CROs and entreprises are getting compliant

Clinical research news

The new EU regulation on General Data Protection is to be applied as of May 25, 2018.

Read more

Surfing the innovation wave, an interview with the Director General EFPIA

January 2, 2018

Clinical research news


Influential industry body, EFPIA, has for years helped pharma improve transparency and repair its long-tainted reputation.

Tackling key issues such as innovation, patient access and collaborative R&D, Eyeforpharma caught up with the new Director General, Nathalie Moll, to discover where their focus is for the next few years and how they plan to support outcomes-driven healthcare across Europe.

Read the full interview here or in the tex below.

Discover more innovative engagement strategies at Barcelona 2018…

This is your chance to hear for the bestmarketers in the industry, including:

  • Sebastian Guth, Chief Marketing Officer, Bayer
  • Mark Mallon, EVP, Global Product Stratagy, AZ
  • Arnaud Lefevre, Head of Operations, N.Europe, UCB
  • Thomas Kerscher, Head Customer Excellence, Shire

For more information on the event organized by EYEFORPHARMA:




Read more

AFMPS/FAGG (FAGG) launches a campaign to encourage participation to clinical trials

December 19, 2017

Clinical research news

Brussel 15 december 2017 - Het Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten (FAGG) lanceert een campagne die aanmoedigt om deel te nemen aan klinische proeven:

 “2031 heeft jou nodig!”

Meer informatie

De brochure en/of affiche kunt u gratis bestellen bij de Afdeling Communicatie van het FAGG via This email address is being protected from spambots. You need JavaScript enabled to view it..

Meer informatie over de campagne vindt u terug op

Bruxelles 15 décembre 2017 – L’Agence fédérale des médicaments et des produits de santé (AFMPS) lance une campagne pour encourager à participer aux essais cliniques :

« 2031 a besoin de vous ! »

Plus d’informations

Vous pouvez commander gratuitement la brochure et/ou affiche auprès de la Division Communication de l’AFMPS via This email address is being protected from spambots. You need JavaScript enabled to view it..

Vous trouverez également plus d’informations sur la campagne sur




Read more